Build status - In Progress

A multicenter double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)

A multicenter double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
Recruiting
18 years - 100 years
All
Phase 3
3 participants needed
1 Location

Brief description of study

The purpose of this study is to find out if the investigational drug, apraglutide and investigational drug , is able to reduce the volume per week of PS required in adults with short bowel syndrome and intestinal failure.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: short bowel syndrome,intestinal failure
  • Age: 18 years - 100 years
  • Gender: All

Male and female patients aged ≥18 years have short bowel syndrome

Updated on 04 Aug 2024. Study ID: 844856

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center